Conversation 175: Forget tea leaf reading - the real money is in plate reading.

Written By Phil Carey

The march of digitisation and technology convergence in health is advancing at an astounding rate.

It covers everything from sophisticated AI disease detection to the time consuming but important task of plate reading in pathology and that is where LBT innovations [ASX:LBT] comes in.

Pathology labs around the world have to manually check tens of thousands of Agar ‘plates’, used to grow bacteria and other microorganisms, every day.

But LBT Innovations [ASX:LBT] has developed a solution to the manual handling based around AI and the company is now entering its global expansion phase.

Phil Carey https://www.cornerstonemedia.com.au
Previous

Conversation 179: Medadvisor says business is well undervalued.
Next

Conversation 173: It is testing time for HeraMED and its pregnancy monitoring system.